The particle therapy market size has grown rapidly in recent years. It will grow from $1.36 billion in 2025 to $1.53 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to rising cancer incidence rates, early adoption of proton therapy technologies, expansion of specialized oncology centers, increasing clinical evidence supporting particle therapy, investments by academic research hospitals.
The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of personalized cancer treatment approaches, increasing healthcare spending on advanced oncology care, growing demand for precision radiation therapies, technological advancements in accelerator systems, rising adoption in emerging healthcare markets. Major trends in the forecast period include increasing adoption of pencil beam scanning systems, rising deployment of single-room particle therapy centers, growing use of carbon ion therapy, expansion of precision treatment planning capabilities, enhanced focus on pediatric oncology applications.
The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.
Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.
In February 2025, Ion Beam Applications S.A. (IBA), a Belgium-based provider of particle accelerator technology and proton therapy solutions, partnered with the Asian Institute of Gastroenterology (AIG) to enhance cancer care in South Asia through advanced proton therapy. Under the partnership, IBA will supply its ProteusONE compact proton therapy system to the new Oncology Centre at AIG Hospitals’ Gachibowli campus in Hyderabad, India, supporting the expansion of state-of-the-art proton therapy capabilities in the region. AIG Hospitals is an India-based healthcare institution specializing in gastroenterology and comprehensive cancer care services.
Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.
North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the particle therapy market by increasing costs of imported accelerators, beam delivery systems, superconducting magnets, imaging components, and control electronics required for proton and heavy ion therapy systems. North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher capital costs for new installations. These tariffs are raising upfront investment requirements and extending project timelines for new therapy centers. However, they are also encouraging local manufacturing partnerships, regional assembly capabilities, and long-term innovation in cost-efficient particle therapy system design.
The particle therapy market research report is one of a series of new reports that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.
Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.
The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of personalized cancer treatment approaches, increasing healthcare spending on advanced oncology care, growing demand for precision radiation therapies, technological advancements in accelerator systems, rising adoption in emerging healthcare markets. Major trends in the forecast period include increasing adoption of pencil beam scanning systems, rising deployment of single-room particle therapy centers, growing use of carbon ion therapy, expansion of precision treatment planning capabilities, enhanced focus on pediatric oncology applications.
The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.
Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.
In February 2025, Ion Beam Applications S.A. (IBA), a Belgium-based provider of particle accelerator technology and proton therapy solutions, partnered with the Asian Institute of Gastroenterology (AIG) to enhance cancer care in South Asia through advanced proton therapy. Under the partnership, IBA will supply its ProteusONE compact proton therapy system to the new Oncology Centre at AIG Hospitals’ Gachibowli campus in Hyderabad, India, supporting the expansion of state-of-the-art proton therapy capabilities in the region. AIG Hospitals is an India-based healthcare institution specializing in gastroenterology and comprehensive cancer care services.
Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.
North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the particle therapy market by increasing costs of imported accelerators, beam delivery systems, superconducting magnets, imaging components, and control electronics required for proton and heavy ion therapy systems. North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher capital costs for new installations. These tariffs are raising upfront investment requirements and extending project timelines for new therapy centers. However, they are also encouraging local manufacturing partnerships, regional assembly capabilities, and long-term innovation in cost-efficient particle therapy system design.
The particle therapy market research report is one of a series of new reports that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.
Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.
The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Particle Therapy Market Characteristics
3. Particle Therapy Market Supply Chain Analysis
4. Global Particle Therapy Market Trends and Strategies
5. Particle Therapy Market Analysis of End Use Industries
7. Global Particle Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Particle Therapy Total Addressable Market (TAM) Analysis for the Market
9. Particle Therapy Market Segmentation
10. Particle Therapy Market Regional and Country Analysis
11. Asia-Pacific Particle Therapy Market
12. China Particle Therapy Market
13. India Particle Therapy Market
14. Japan Particle Therapy Market
15. Australia Particle Therapy Market
16. Indonesia Particle Therapy Market
17. South Korea Particle Therapy Market
18. Taiwan Particle Therapy Market
19. South East Asia Particle Therapy Market
20. Western Europe Particle Therapy Market
21. UK Particle Therapy Market
22. Germany Particle Therapy Market
23. France Particle Therapy Market
24. Italy Particle Therapy Market
25. Spain Particle Therapy Market
26. Eastern Europe Particle Therapy Market
27. Russia Particle Therapy Market
28. North America Particle Therapy Market
29. USA Particle Therapy Market
30. Canada Particle Therapy Market
31. South America Particle Therapy Market
32. Brazil Particle Therapy Market
33. Middle East Particle Therapy Market
34. Africa Particle Therapy Market
36. Particle Therapy Market Competitive Landscape and Company Profiles
37. Particle Therapy Market Other Major and Innovative Companies
40. Particle Therapy Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Particle Therapy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for particle therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The particle therapy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Proton Therapy; Heavy Ion Therapy2) By System: Single-Room Systems; Multi-Room Systems
3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
4) By End-User: Hospital; Academic And Research Centers
Subsegments:
1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy
Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; IBA Worldwide; Mevion Medical Systems Inc.; ProNova Solutions LLC; Advanced Oncotherapy plc; Shinva Medical Instrument Co. Ltd.; Optivus Proton Therapy Inc.; Protom International Inc.; Danfysik AS; Toshiba Energy Systems And Solutions Corporation; Canon Medical Systems Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare; Elekta AB; Accuray Incorporated; Xstrahl Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Particle Therapy market report include:- Hitachi Ltd.
- Mitsubishi Electric Corporation
- Sumitomo Heavy Industries Ltd.
- Varian Medical Systems Inc.
- IBA Worldwide
- Mevion Medical Systems Inc.
- ProNova Solutions LLC
- Advanced Oncotherapy plc
- Shinva Medical Instrument Co. Ltd.
- Optivus Proton Therapy Inc.
- Protom International Inc.
- Danfysik AS
- Toshiba Energy Systems And Solutions Corporation
- Canon Medical Systems Corporation
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE Healthcare
- Elekta AB
- Accuray Incorporated
- Xstrahl Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.53 Billion |
| Forecasted Market Value ( USD | $ 2.44 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
